{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:33:42Z","timestamp":1790472822301,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.antiviral.2006.02.010","type":"journal-article","created":{"date-parts":[[2006,3,30]],"date-time":"2006-03-30T07:52:14Z","timestamp":1143705134000},"page":"24-30","source":"Crossref","is-referenced-by-count":119,"title":["In vitro and in vivo evaluation of isatin-\u03b2-thiosemicarbazone and marboran against vaccinia and cowpox virus infections"],"prefix":"10.1016","volume":"71","author":[{"given":"Debra C.","family":"Quenelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy A.","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earl R.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2006.02.010_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.02.010_bib2","first-page":"105","article-title":"The antiviral and synergic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice","volume":"36","author":"Bauer","year":"1955","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.antiviral.2006.02.010_bib3","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0140-6736(60)90990-9","article-title":"New antiviral chemotherapeutic agent active against smallpox infection","volume":"1","author":"Bauer","year":"1960","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2006.02.010_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.1965.tb12545.x","article-title":"Clinical experience with the antiviral drug marboran (1-methylisatin 3-thiosemicarbazone)","volume":"130","author":"Bauer","year":"1965","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.antiviral.2006.02.010_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1749-6632.1965.tb12544.x","article-title":"Monocyclic thiosemicarbazones as antiviral agents","volume":"130","author":"Bauer","year":"1965","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.antiviral.2006.02.010_bib6","first-page":"544","article-title":"Chemoprophylaxis of smallpox and treatment of vaccinia gangrenosa with 1-methylisatin 3-thiosemicarbazone","volume":"5","author":"Bauer","year":"1965","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.02.010_bib7","first-page":"727","article-title":"The chemotherapy of variola major infection","volume":"26","author":"Bauer","year":"1962","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.antiviral.2006.02.010_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/oxfordjournals.aje.a121057","article-title":"Prophylaxis of smallpox with methisazone","volume":"90","author":"Bauer","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2006.02.010_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0140-6736(63)90230-7","article-title":"Prophylactic treatment of smallpox contacts with n-methylisatin \u03b2-thiosemicarbazone","volume":"ii","author":"Bauer","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2006.02.010_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01314907","article-title":"Effect of N,N\u2032-bis (methylisatin-beta-thiosemicarbazone)-2-methylpiperazine on vaccinia virus replication in vitro and in vivo","volume":"62","author":"Borysiewicz","year":"1979","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2006.02.010_bib11","first-page":"536","article-title":"Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice","volume":"6","author":"Boyle","year":"1966","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.02.010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.02.010_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00624524","article-title":"\u00dcber eine neue, gegen Tuberkelbazillen in vitro wirksame Verbindungsklasse","volume":"10","author":"Domagk","year":"1946","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.antiviral.2006.02.010_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a121340","article-title":"Field trials of methisazone as a prophylactic agent against smallpox","volume":"94","author":"Heiner","year":"1971","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2006.02.010_bib15","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/AAC.47.7.2193-2198.2003","article-title":"Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication","volume":"47","author":"Keith","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.02.010_bib16","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.49.8.3153-3162.2005","article-title":"Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate","volume":"49","author":"Magee","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.02.010_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-3542(02)00197-3","article-title":"Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives","volume":"57","author":"Neyts","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.02.010_bib18","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1021\/jm049147h","article-title":"Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-pox agents","volume":"48","author":"Pirrung","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2006.02.010_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1568005053174627","article-title":"Orthopoxvirus targets for the development of antiviral therapies","volume":"5","author":"Prichard","year":"2005","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"10.1016\/j.antiviral.2006.02.010_bib20","doi-asserted-by":"crossref","first-page":"44858","DOI":"10.1074\/jbc.M408167200","article-title":"An Isatin-\u03b2-thiosemicarbazone-resistant vaccinia virus containing a mutation in the second largest subunit of the viral RNA polymerase is defective in transcription elongation","volume":"279","author":"Prins","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2006.02.010_bib21","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/AAC.47.10.3275-3280.2003","article-title":"Efficacy of multiple-or single-dose cidofovir against vaccinia and cowpox infections in mice","volume":"47","author":"Quenelle","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.02.010_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2004.02.003","article-title":"Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir","volume":"63","author":"Quenelle","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.02.010_bib23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.48.2.404-412.2004","article-title":"Oral treatment of cowpox and vaccinia infections in mice with ether lipid esters of cidofovir","volume":"48","author":"Quenelle","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.02.010_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-6632.1965.tb12546.x","article-title":"The laboratory and clinical assessment of an isothiazole thiosemicarbazone (M&B 7714) against pox viruses","volume":"130","author":"Rao","year":"1965","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.antiviral.2006.02.010_bib25","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/422696","article-title":"Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice","volume":"190","author":"Smee","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.02.010_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00199-7","article-title":"A review of compounds exhibiting anti-orthopoxvirus activity in animal models","volume":"57","author":"Smee","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.02.010_bib27","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.1.5288.1317","article-title":"Eczema vaccinatum treated with N-methylisatin beta-thiosemicarbazone","volume":"i","author":"Turner","year":"1962","journal-title":"Br. Med. J."},{"key":"10.1016\/j.antiviral.2006.02.010_bib28","first-page":"187","article-title":"Evaluation of ectodermal lesions in intravenous vaccinia infected mice as a method to investigate the antiviral activity of isatin beta-thiosemicarbazone derivative (TSK VI compound)","volume":"29","author":"Walter","year":"1981","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.antiviral.2006.02.010_bib29","first-page":"439","article-title":"Effect of N,N\u2032-bis(methylisatin-beta-thiosemicarbazone)-2-methylpiperazine against virus-induced encephalitis in mice","volume":"24","author":"Zgornaik-Nowosielska","year":"1980","journal-title":"Acta. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T14:14:56Z","timestamp":1555510496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354206000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0166354206000647"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2006.02.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}